<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Erythrocyte properties of patients with <z:hpo ids='HP_0004810'>congenital hypoplastic anemia</z:hpo> were compared to those of patients with <z:hpo ids='HP_0005510'>transient erythroblastopenia</z:hpo> of childhood </plain></SENT>
<SENT sid="1" pm="."><plain>The MCV was less than 85 in <z:hpo ids='HP_0000001'>all</z:hpo> nine TEC patients studied and greater than 90 in <z:hpo ids='HP_0000001'>all</z:hpo> 11 CHA patients </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="35143">Hemoglobin</z:chebi> F concentration was elevated beyond the <z:mpath ids='MPATH_458'>normal</z:mpath> level for age in eight CHA patients and almost always <z:mpath ids='MPATH_458'>normal</z:mpath> in TEC </plain></SENT>
<SENT sid="3" pm="."><plain>The i antigen score was more likely to be elevated in CHA than in TEC </plain></SENT>
<SENT sid="4" pm="."><plain>The activities of transaminase, aldolase, phosphofructokinase, and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase were higher in CHA than in TEC (p less than 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>Some abnormal properties (namely, MCV and hemoglobi n F concentration) of CHA erythrocytes, present during remission but accentuated during relapse, seemed to vary with changes in serum erythropoietin </plain></SENT>
<SENT sid="6" pm="."><plain>Early differentiation of TEC and CHA appears feasible, allowing prompt provision of a favorable prognosis and the avoidance of unnecessary <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy in TEC </plain></SENT>
</text></document>